All Posts: Georgetown Lombardi
-
Georgetown’s Cancer Center Awarded Top Designation by Federal Government
The National Cancer Institute (NCI), a part of the National Institutes of Health, has awarded its most prestigious designation — “comprehensive cancer center” status — to Georgetown University‘s Lombardi Comprehensive Cancer Center in recognition of its high-impact research, community outreach and cancer care. Georgetown Lombardi is the only such center in the Washington area.
Category: News Release
-
The Aspirin Conundrum: Navigating Negative Results, Age, Aging Dynamics and Equity
A new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging that have broad implications for cancer and other disease intervention trials, say researchers from Georgetown University’s Lombardi Comprehensive Cancer Center. They outline their concerns in an editorial accompanying the study’s findings published April 29 in the JAMA.
Category: News Release
-
Psychosocial Oncology Program Promotes Cura Personalis in Cancer Care
As director of the psychosocial oncology program at Georgetown Lombardi, Kimberly M. Davis, PhD, supports the psychological needs of cancer patients, while also training future independent clinical researchers in the field.
Category: GUMC Stories
-
New Georgetown Lombardi Office Cultivates Diversity, Equity and Inclusion at the Cancer Center
Despite significant advances in cancer prevention, screening, diagnosis and treatment over the last several decades, persistent cancer health disparities disproportionately impact populations who have been historically underrepresented in science and medicine. Diversity in cancer research and education is a critical part of changing that paradigm. And critical to achieving that is cultivating an inclusive environment at work — the goal of the new Office of Diversity, Equity and Inclusion at Georgetown Lombardi.
Category: GUMC Stories
-
Could a Georgetown Lab Finding Lead to New Treatment in Pancreatic Cancer?
For the first time, new research by Georgetown scientists shows potential to make immunotherapy effective in pancreatic cancer by combining it with a drug that makes cancer cells more responsive to immunotherapy.
Category: GUMC Stories
-
Staying Hands-on in Hope: For the Future of Pediatric Cancer Research (and Maybe a New Car)
The Hyundai Hands On Hope contest, generously sponsored by the Washington Area Hyundai Dealers, ran January 19 to 21 and featured healthy competition between Georgetown Lombardi and Children’s National.
Category: GUMC Stories
-
2023 Men’s Event Returns in Support of Cancer Research at Georgetown Lombardi
More than 150 men gathered for the 23rd Annual Men’s Event to help raise money and awareness for cancer research in support of Georgetown University’s Lombardi Comprehensive Cancer Center.
Category: GUMC Stories
-
Called To Be a Space Biologist, Postdoc Participates in Selective NASA Program
A NASA program is putting Georgetown postdoctoral fellow Geraldine Vitry, PhD, a step closer to realizing her goal of contributing to humans walking on Mars.
Category: GUMC Stories
-
Tobacco Regulations Center Receives $20 Million for Tobacco Use Research
The Center for the Assessment of Tobacco Regulations (CAsToR) — a collaboration among Georgetown University, the University of Michigan, and the British Columbia (BC) Cancer Research Institute — recently received $20 million in funding to continue its research on the impact of tobacco regulations on tobacco use patterns and their downstream health effects.
Category: News Release
-
BellRinger 2023 Celebrates Community Dedicated to Ending Cancer
BellRinger’s second annual ride brought together nearly 1,000 riders, more than 400 volunteers and countless supporters, all committed to giving researchers at Georgetown University’s Lombardi Comprehensive Cancer Center the funding they need to prevent, treat and cure cancer.
Category: GUMC Stories